- Home
- MTR vs SILO Comparison
MTR vs SILO Comparison
Compare MTR & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTR
- SILO
- Stock Information
- Founded
- MTR 1979
- SILO 2010
- Country
- MTR United States
- SILO United States
- Employees
- MTR N/A
- SILO N/A
- Industry
- MTR Oil & Gas Production
- SILO Apparel
- Sector
- MTR Energy
- SILO Consumer Discretionary
- Exchange
- MTR Nasdaq
- SILO Nasdaq
- Market Cap
- MTR 8.6M
- SILO 8.0M
- IPO Year
- MTR N/A
- SILO N/A
- Fundamental
- Price
- MTR $4.58
- SILO $0.41
- Analyst Decision
- MTR
- SILO
- Analyst Count
- MTR 0
- SILO 0
- Target Price
- MTR N/A
- SILO N/A
- AVG Volume (30 Days)
- MTR 16.0K
- SILO 368.3K
- Earning Date
- MTR 01-01-0001
- SILO 11-13-2025
- Dividend Yield
- MTR 4.48%
- SILO N/A
- EPS Growth
- MTR N/A
- SILO N/A
- EPS
- MTR 0.23
- SILO N/A
- Revenue
- MTR $623,288.00
- SILO $72,102.00
- Revenue This Year
- MTR N/A
- SILO $1.86
- Revenue Next Year
- MTR N/A
- SILO N/A
- P/E Ratio
- MTR $19.72
- SILO N/A
- Revenue Growth
- MTR N/A
- SILO N/A
- 52 Week Low
- MTR $4.29
- SILO $0.39
- 52 Week High
- MTR $10.42
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- MTR 42.77
- SILO 27.06
- Support Level
- MTR $4.50
- SILO $0.39
- Resistance Level
- MTR $4.69
- SILO $0.47
- Average True Range (ATR)
- MTR 0.20
- SILO 0.04
- MACD
- MTR 0.03
- SILO -0.00
- Stochastic Oscillator
- MTR 47.99
- SILO 3.62
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.